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Background. To learn upon incidence and reasons for distal stent-graft induced new entry 
(dSINE) after thoracic endovascular aortic repair (TEVAR) or after frozen elephant trunk 
(FET) implantation, and to develop prevention algorithms. 
Methods. Analysis of an international multi-center registry (European Registry of 
Endovascular Aortic Repair Complications- EuREC), 69 dSINE patients out of 1430 TEVAR 
patients for type B aortic dissection (4,8 %) and 6 dSINE patients out of 100 patients after the 
FET procedure for aortic dissection (6 %) with secondary morphological comparison.  
Results. The underlying aortic pathology was acute type B aortic dissection in 33 patients 
(44%), subacute and/ or chronic type B aortic dissection in 34 patients (45%), acute type A 
aortic dissection in 3 patients and remaining dissection after type A repair in 3 patients (8%), 
acute type B intramural hematoma in 2 patients (3%). dSINE occurred in 4.4% of patients in 
the acute setting and in 4.9% of patients in the subac te/ chronic setting after TEVAR . After, 
the FET procedure, dSINE occurred in 5.3% of patients in the acute setting and in 6.5% of 
patients in the chronic setting.  The interval between TEVAR/ FET and the diagnosis of 
dSINE was 489 ± 681 days. Follow-up after dSINE was 1340 ± 1151days, 4 patients 
developed recurrence of dSINE (5%). Morphological analysis between patients after TEVAR 
with and without dSINE showed a smaller true lumen (TL) diameter, a more accentuated oval 
TL morphology and a higher degree of stent-graft oversizing in patients who have d veloped 
dSINE. 
Conclusions. dSINE after TEVAR/ FET is not rare and occurs with similar incidence after 
acute and chronic aortic dissection- early and late. Avoiding oversizing in the acute and in the 
chronic setting as well as carefully selecting patients for TEVAR in post-dissection 
aneurysmal formation will aid in reducing the incidence of dSINE to a minimum.  
 
Keywords: TEVAR, distal stent-graft induced new entry, complications, treatment 
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Thoracic endovascular aortic repair (TEVAR) since its introduction in the late 90ies, 
has become the standard treatment for various thoracic aortic pathology in particular in 
patients with acute complicated type B aortic dissection (1-5). However, as with each and 
every new treatment modality, limitations and complications become apparent. One of them 
when choosing the TEVAR/ FET approach was stent-graf  induced new entry (SINE) either 
proximal (often leading to retrograde type A aortic dissection) or distal (dSINE- usually 
leading to antegrade false lumen reperfusion) (6-10). Knowledge regarding dSINE developed 
gradually Japanese and Chinese series pioneered knowledge and a recent review summarized 
the currently known key components (11-13). However, no multicenter effort pooling a large 
cohort of patients is available. 
 
The aim of this study was to learn upon incidence and reasons for dSINE after 
TEVAR or FET and to develop prevention algorithms to reduce the remaining risk of 
occurrence to a minimum.  
 
Patients and Methods 
Patients. Analysis of an international multi-center registry (European Registry of 
Endovascular Aortic Repair Complications- EuREC from November 1999 to March 2017), 69 
dSINE patients out of 1430 TEVAR patients for type B aortic dissection (4,8 %) and 6 dSINE 
patients out of 100 patients after the FET procedur for aortic dissection (6 %). Secondary 
morphological comparison of the acute type B subgroup having developed dSINE with 
patients after TEVAR for acute type B aortic dissection without development of dSINE. 
  
Definition of dSINE, definition of true lumen shape (definition of ovality) and levels of 
measurement and evaluation of aortic TL and FL diameter and thrombosis status.  dSINE 
was defined as any newly detected communication between lumina at the distal end of the 
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stent-graft having been absent either during primary implantation or during completion 
imaging at follow-up. Oval true lumen shape was defined as difference between the long and 
the short axis diameter at the distal end of the stent-graft as shown in Figure 1. The long axis 
length was used to predict the pre-dissection aortic diameter in patients with acute dissection. 
In these patients, stent-graft diameter was chosen according to predicted pre-dissection aortic 
diameter with 0% oversizing. In case of chronic aortic dissection the average true lumen 
diameter (according to long and short axis) was used and about 10% oversizing was applied in 
the first author’s center.  
 
Parameters. We collected clinical data, including any kind of previous aortic surgery 
or intervention, underlying aortic pathology and extension of aortic disease. Procedural data 
included the index TEVAR procedure, elective or emergent intervention, number of 
prostheses, covered length and landing zones according to current definitions. The false 
lumen thrombosis status at different levels was recorded as was the timepoint of occurrence of 
dSINE. We collected treatment strategies applied and finally compared aortic diameters and 
aortic shape in patients having had TEVAR for acute typ  B aortic dissection developing 
dSINE with aortic diameters and aortic shape in a control group of patients having had 
TEVAR for acute type B aortic dissection not developing dSINE. We did not collect data 
regarding side-branch stenting during the index procedure. Information on clinical outcome 
after distal TEVAR extension or after open surgery was not collected. 
 
Statistical analysis. All values are shown as number (percentage) or as mean ± 
standard deviation. IBM SPSS Statistics 24 for Macintosh (Armonk; NY) was used for 
statistical analysis. The University Heart Centre Fiburg´s acute type B aortic dissections 
database served to compare the aortic as well as the stent-graft diameters. The Mann-Whitney 
U test was used to compare continuous variables between both groups.  




Patient demographics. Patient demographics are shown in Table 1. Mean age was 58 
± 13 years and 24% had any kind previous aortic operation or intervention. 
 
Aortic characteristics. The underlying aortic pathology was acute type B aortic 
dissection in 33 patients (44%), subacute and/ or chronic type B aortic dissection in 34 
patients (45%), acute type A aortic dissection in 3patients and remaining dissection after type 
A repair in 3 patients (8%), acute type B intramural hematoma in 2 patients (3%). In patients 
with chronic type B aortic dissection, the interval between the acute event and TEVAR was 
472 ± 715 days. The presumed etiology as well as the extent of the dissective process are 
shown in Table 2. The main indications for TEVAR were malperfusion and (contained) 
rupture in the acute phase and diameter increase in th  subacute and chronic phase. 
 
Procedural characteristics- index procedure. Forty-six procedures were performed 
electively whereas 36% were performed under emergency conditions. Procedural details are 
shown in Table 3. Table 4 shows the thrombosis status of the false lumen at different levels 
after the index procedure. Fifteen patients received tapered stent-grafts whereas 8 had a 
primary tapered prosthesis and another 7 had a tapered stent-graft as the most distal 
prosthesis.  One patient received a bare stent distal ex ension during the index procedure. 
 
dSINE incidence and time interval to index procedure. dSINE was observed in 69 out 
of 1430 patients after TEVAR (4,8 %) and in 6 out of 100 patients after the FET procedure (6 
%). dSINE occurred in 4.4% of patients in the acute setting (33 out of 739 patients) and in 
4.9% of patients in the subacute/ chronic setting after TEVAR (34 out of 691 patients). After 
the FET procedure, dSINE occurred in 5.3% in the acute setting (3 out of 54 patients) and in 
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6.5% in the chronic setting (3 out of 46 patients).   The interval between TEVAR/ FET and 
the diagnosis of dSINE was 489 ± 681 days.  
 
dSINE management. In 28 patients (37%) a conservative approach was cho en, 42 
patients (56%) underwent TEVAR extension and 5 patients (7%) underwent open surgical 
conversion. Follow-up after dSINE was 1340 ± 1151days, 4 patients developed recurrence of 
dSINE (5%) (Table 5). Figure 2 shows CTA scans of a patient with the recurrent occurrence 
of dSINE. 
 
Aortic diameters in patients with and without dSINE. Morphological analysis between 
patients after TEVAR with and without dSINE showed a smaller TL diameter (23 ± 7 vs. 34 ± 
6, p < 0.001), a more accentuated oval postoperativ s ent-graft morphology (5 ± 4 (ratio 
1:1.18) vs. 2 ± 2 (ratio 1:1.08) , p < 0.001) and a higher degree of stent-graft oversizing in 
patients having developed dSINE (10 ± 6 vs. 3 ± 6, p < 0.001) (Table 6). The entire 
measurements in several aortic segments are summarized in Supplemental Table 1. 
 
Comment 
The majority of patients had acute type B aortic dissection as the underlying aortic 
pathology warranting TEVAR, followed by a high number of patients undergoing TEVAR for 
subacute and chronic type B aortic dissection. Where type B aortic dissection has been 
regarded as the hazard-free dissection without the need for treatment in many cases, recent 
knowledge upon risk factors for the presence or the development of early or late 
complications has completely turned the page (4,15-17). This has led to a broader application 
of TEVAR in this patient cohort which per se also leads to a potentially higher number of 
patients sustaining early or late complications such as dSINE. 
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Also in patients with post-dissection aneurysmal formation, TEVAR has gained 
widespread acceptance but it has to be taken into the consideration that TEVAR alone is 
rarely capable to effectively treat the complex underlying pathology where the efficacy is 
strongly dependent on various conditions (18). As to the nature of the disease, the membrane 
has often stiffened over time and the potential for remodeling is lower. Therefore, the shear-
stress between the distal end of the stent-graft and the dissection membrane is high and may 
cause dSINE- early or late- tapered stent-graft seem to play a major role in reducing dSINE to 
a minimum in these clinical scenarios. Despite FET and TEVAR being different conceptual 
approaches, the pathophysiological mechanisms behind t e occurrence of dSINE are very 
similar. 
 
Results after surgery for acute type A aortic dissection have made a leap towards 
lower mortality in the last two decades and the FET technique is applied more frequently (19-
21). As many patients will undergo a stringent follow-up in an aortic outpatient clinic, 
aneurysm formation in residual dissection after type A repair is frequently seen. (22,23). The 
FET technique is applied in patients with acute type A aortic dissection, mainly in those 
where the primary entry tear cannot be excluded by surgical means due to its distal location 
(24,25). Similar to classical TEVAR, the interaction betwen the distal end of the stent-graft 
and the dissection membrane may lead to dSINE due to the before mentioned mechanism 
with the addition that the stent-graft design of the FET prosthesis might also play an important 
role with regard to distribution of radial force (26). 
 
With regard to procedural characteristics, there was an even distribution between acute 
and chronic indications for both TEVAR and FET. Manufacturer, size as well as number of 
prostheses were evenly distributed and in the majority f patients. 
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The incidence of dSINE was similar between the acute and the chronic setting after 
both- TEVAR and the FET procedure indicating mechanisms of occurrence beyond the 
timepoint of treatment. The high mean variation when dSINE occurred- early or late after the 
index procedure- shows the unpredictability. Interestingly, dSINE frequently was a diagnosis 
by chance during follow-up and was rarely associated with acute chest pain which is 
frequently seen in acute aortic dissection irrespectiv  of type. Treatment approaches varied 
substantially from conservative therapy to thoracoabdominal replacement (27). As these are 
registry data and imaging was not available, the reasons why one or the other treatment 
modality was chosen, remain speculative.  
 
As a classical control group is lacking, we aimed at understanding similarities and 
differences between patients with and without developing dSINE. Consequently, we selected 
the subgroup of patients who underwent TEVAR for acute type B aortic dissection and 
compared aortic diameter and shape at the level of the distal end of the stent-graft with 
patients who underwent TEVAR for acute type B aortic dissection in the first author´s 
institution who did not develop dSINE. Patients developing dSINE had both- a smaller true 
lumen diameter and a more oval true lumen shape indicating true lumen compression and 
eventually malperfusion during the initial phase and eventually most important, that 
oversizing of the stent-grafts used was more frequent in the ones who developed dSINE 
underlining the importance of sizing. Recent evidence suggested that dSINE occurs more 
frequently in the hyperacute stage which prompted many do delay therapy if the clinical 
course permits to do so. When we set up this study, we did not differentiate into hyperacute 
and acute which does not let us to distinguish betwe n these two phases. 
 
Rationale for aggressive treatment- From a functional point of view in primary type B aortic 
dissection, we do have data to correlate the size of the primary entry tear to progression of 
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disease in particular with regard to diameter progression. This mirrors exactly what we do 
observe in dSINE- rapid diameter increase in the majority of cases. This is what drives the 
attitude to follow an aggressive treatment strategy. 
 
Stent-graft sizing in patients with acute type B aortic dissection is demanding and 
several options are available. Most importantly, one has to understand that during the acute 
event, there is an acute diameter increase in particular in the proximal descending aorta by 
20%, this has been shown by retrospective imaging studies (28). However, the proximal 
landing zone remains the most important determinant when choosing the appropriate stent-
graft size- tapered devices present a very good solution in combining both- needs and 
demands- regarding the correct stent-graft size. 
 
 
Recently, new approaches like the PETTICOAT or the STABILIZE concept have 
entered the clinical arena and it remains to be shown if their routine use will be able to further 
reduce the occurrence of dSINE (29,30). Additionally, a “distal first” concept of deployment 
in case of at least 2 prostheses has been advocated to prevent dSINE which also remains to be 
confirmed by larger studies (13). 
  
Limitations and strengths. This analysis has all limitations associated with 
retrospectively collected registry data. Potential coding errors, absence of external validation 
and interobserver variability in particular due to the lack of imaging data for detailed 
morphologic analyses. On the other hand, this is a respectively large series of a new disease 
where- to date- little has been known with regard to incidence, mechanisms behind the 
development and finally, where initial recommendations for prevention can be provided. 
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Summarizing, dSINE after TEVAR/ FET is not rare and occurs with similar incidence 
after acute and chronic aortic dissection- early and l te. Avoiding oversizing in the acute and 
in the chronic setting as well as carefully selecting patients for TEVAR in post-dissection 
aneurysmal formation will aid in reducing the incidence of dSINE to a minimum. 
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Figure 1. The CTA scan shows the measurement of the ovality of the stent-graft at the distal 
end and it´s calculation. 
 
Figure 2. (A) Postoperative computed tomography angiography (CTA) scan of a patient after 
total aortic arch replacement via the frozen elephant trunk technique. (B) Follow-up CTA revealed 
a dSINE and was treated by TEVAR (C) In the same pati nt a dSINE occurred once again (D) and 
was treated by TEVAR once more (E). 








   Male 50 (67) 
   Age 58 ± 13 
Medical history  
   Hypertension  68 (91) 
   Coronary Artery Disease 11 (15) 
   Previous CABG 4 (5) 
   Previous aortic surgery/intervention* 18 (24) 
Ascending 16 (21) 
Arch 5 (7) 
Descending 2 (3) 
Abdominal 0 (0) 
Data are presented as number (%); CABG, coronary artery bypass grafting *multiple mentions possible 
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Table 2- Aortic characteristics 
 
 n=75 
Underlying aortic disease  
   Acute type A dissection/ remaining dissection after type A repair 6 (8) 
   Acute type B dissection 33 (44) 
   Subacute/chronic type B dissection 34 (45) 
   Intramural hematoma 2 (3) 
Days between acute event and TEVAR in chronic type B aortic dissection 472 ± 715 
Presumed etiology*  
   Atherosclerotic/hypertensive 61 (81) 
   Degenerative 7 (9) 
   Connective tissue disease 5 (7) 
   Traumatic 2 (3) 
   Other 1 (1) 
Extension of dissection  
    Descending  1 (1) 
    Abdominal 23 (31) 
    Iliac arteries 49 (65) 
   N/A 2 (3) 




Czerny et al. 
21 
 
Table 3- Procedure characteristics 
 n=75 
Type of procedure  
   Elective 46 (61) 
   Emergency 27 (36) 
   N/A 2 (3) 
Type of Prosthesis*  
   Medtronic © 32 (43) 
   Gore © 16 (21) 
   Bolton Medical © 20 (27) 
   Vascutek © 6 (8) 
   N/A 2 (3) 
Number of prostheses  
   n=1 63 (84) 
   n=2 8 (11) 
   n=3 4 (5) 
Landing zone  
   Zone 2 47 (63) 
   Zone 3 27 (36) 
   Zone 4 1 (1) 
Intended or accidental overstenting of arch vessels 35 (47) 
  Left subclavian artery 34 (45) 
  Brachiocephalic trunk  1 (1) 
Supraaortic transposition* 21 (28) 
   Carotid-subclavian bypass 21(28) 
   Extraanatomic bypass to the left subclavian artery 1 (1) 
   Ascendo-Bicarotical bypass 1 (1) 
Distal part of the stent-graft crosses thoracoabdominal transition 9 (12) 
Distal extension with bare stent 1 (1) 
Covered length, mm 174 ± 51 
Data are presented as number (%) or as mean ± standard deviation; mm, milimetre; *,multiple mentions 
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Table 4- Early and late postoperative aortic characteristics 
 
 n=75 
Immediate postoperative false lumen status at stent-graf  level  
  Thrombosed 45 (60) 
  Partially thrombosed 26 (35) 
  Patent 3 (4) 
Immediate postoperative false lumen status at thoracoabdominal 
transition 
 
  Thrombosed 16 (21) 
  Partially thrombosed 25 (33) 
  Patent 32 (43) 
  N/A 2 (3) 
Occurrence of dSINE, days since TEVAR                                                   489 ± 681 
False Lumen Status at stent-graft level (at diagnosis of dSINE)  
  Thrombosed 28 (37) 
  Partially thrombosed 36 (48) 
  Patent 9 (12) 
  N/A 2 (3) 
False Lumen Status at thoracoabdominal transition (at diagnosis of 
dSINE) 
 
  Thrombosed 14 (19) 
  Partially thrombosed 23 (31) 
  Patent 35 (47) 
  N/A 3 (4) 
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Table 5- Management dSINE 
 
 n=75 
  Conservative 28 (37) 
  TEVAR extension 42 (56) 
  Classical surgery 5 (7) 
Follow-up after dSINE, days 1340 ± 1151 
Recurrence of dSINE 4 (5) 
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Table 6- Aortic diameters 
 
  
 dSINE (+) dSINE (-) p-value 
Patients with acute type B dissection 33 71  
Mean preoperative true lumen diameter mm 23 ± 7 34 ± 6 <0.001 
Covered length, mm 171 ± 42 150 ± 35 0.013 
Mean stent diameter, mm 33 ± 5 37 ± 5 <0.001 
Postoperative stent diameter ovality, mm 5 ± 4 2 ± 2 <0.001 
Mean oversizing, mm 10 ± 6 3 ± 6 <0.001 
Data are presented as number (%) or as mean ± standard deviation; N/A, not available; mm, milimeter 
 
 
 
 
 
  
 
 
 


